Adaptation of 3DNA Dendrimers to Point of Care Assays

Lateral Flow (LF) and similar assays represent a unique growing class of Point of Care (POC) tests designed to rapidly diagnose patients within clinically actionable timeframes. This technical note describes how 3DNA^® Dendrimer technology was applied to a model LF POC assay, resulting in a 64 fold improvement of sensitivity.